- Sun Pharma
Managing Director: Dilip Shanghvi
Sun Pharmaceutical Industries Limited stands as India’s largest pharmaceutical company and ranks among the top six generic drug manufacturers globally. The company develops and markets a wide range of pharmaceutical formulations and active pharmaceutical ingredients (APIs), serving patients across more than 100 countries. In a recent strategic move, Sun Pharma completed the acquisition of 100 percent equity in Libra Merger Ltd, an Israel-based firm.
- Laborate
Director – Arpit Bhatia, Laborate
Laborate Pharmaceuticals India Ltd. is one of India’s leading pharmaceutical manufacturers, recognised for its high-quality formulations and growing global footprint. The company develops, manufactures, and markets a wide range of medicines across therapeutic segments including antibiotics, pain management, cardiovascular, and dermatology. With a presence in over 30 countries, Laborate delivers affordable and effective healthcare solutions to millions worldwide through its advanced manufacturing facilities and strong R&D capabilities.
- Cipla
MD & Global CEO: Umang Vohra
Founded in 1935 by Khwaja Abdul Hamied, Cipla Limited is one of India’s most trusted and diversified pharmaceutical companies. Operating through two key segments Pharmaceuticals and New Ventures the company focuses on developing and delivering high-quality, affordable medicines across therapeutic areas such as respiratory care, cardiovascular health, diabetes management, and mental well-being. With a strong global presence, Cipla continues to drive innovation and access to healthcare in over 80 countries worldwide.
- Mankind Pharma
CEO: Sheetal Arora
Incorporated in 1995, Mankind Pharma Limited is one of India’s leading pharmaceutical companies, known for its wide portfolio spanning antibiotics, gastrointestinal, cardiovascular, dermatological, and erectile dysfunction therapies. The company is committed to delivering affordable, high-quality healthcare solutions and improving patient outcomes across diverse medical needs. Demonstrating its focus on advanced research and innovation, Mankind Pharma made an additional investment of £1 million in Actimed Therapeutics in 2023 to support the development of novel treatments for cancer cachexia, amyotrophic lateral sclerosis (ALS), and other muscle-wasting disorders.
- Dr. Reddy’s Lab
Co-chairman & MD: GV Prasad
Founded by Dr. Kallam Anji Reddy, Dr. Reddy’s Laboratories is a leading Indian multinational pharmaceutical company with a strong presence across global markets. Leveraging decades of research expertise and innovation, the company develops, manufactures, and markets a wide spectrum of high-quality medicines and active pharmaceutical ingredients (APIs) across major therapeutic areas. Strengthening its focus on women’s health and wellness, Dr. Reddy’s Laboratories recently acquired MenoLabs from Amyris Inc., expanding its portfolio in dietary supplements and holistic healthcare solutions.
- Aurobindo Pharma
Executive Chairman: P.V. Ramprasad Reddy
Founded in 1986 by Penaka Venkata Ramprasad Reddy and Kambam Nithyananda Reddy, Aurobindo Pharma Limited is one of India’s leading pharmaceutical companies, known for its strong presence in the production of generic medicines and active pharmaceutical ingredients (APIs). The company has built a robust global footprint through its commitment to quality, affordability, and innovation across multiple therapeutic segments. In a recent development, one of its subsidiaries received approval from the United States Food and Drug Administration (USFDA) for Posaconazole Injection, a key treatment used to prevent severe fungal infections.
- Lupin Limited
Managing Director: Sharvil P. Patel
Lupin Limited is one of India’s leading pharmaceutical companies and ranks among the top global manufacturers of generic medicines. With a strong commitment to quality, innovation, and accessibility, the company operates across key therapeutic areas including paediatrics, cardiovascular health, anti-infectives, diabetology, respiratory care, and anti-tuberculosis treatments. Backed by world-class R&D and a growing international presence, Lupin continues to advance its mission of providing affordable healthcare solutions to patients in over 100 countries.